IRIS
MUSOLINO, Caterina
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.831
EU - Europa 4.999
AS - Asia 1.714
SA - Sud America 15
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 4
AF - Africa 3
Totale 12.577
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.800
IE - Irlanda 1.510
SE - Svezia 1.242
CN - Cina 784
SG - Singapore 775
IT - Italia 717
UA - Ucraina 356
DE - Germania 312
FI - Finlandia 232
PL - Polonia 179
GB - Regno Unito 150
FR - Francia 63
HU - Ungheria 59
IN - India 58
BE - Belgio 54
AT - Austria 37
VN - Vietnam 28
NL - Olanda 26
CA - Canada 25
ID - Indonesia 23
IR - Iran 17
RU - Federazione Russa 13
CZ - Repubblica Ceca 11
BR - Brasile 10
RO - Romania 8
AU - Australia 7
ES - Italia 6
KR - Corea 6
CH - Svizzera 5
DK - Danimarca 5
MX - Messico 5
TW - Taiwan 5
EU - Europa 4
IL - Israele 4
NZ - Nuova Zelanda 4
CO - Colombia 3
HK - Hong Kong 3
LT - Lituania 3
NO - Norvegia 3
TR - Turchia 3
BG - Bulgaria 2
GR - Grecia 2
JP - Giappone 2
AM - Armenia 1
CL - Cile 1
DO - Repubblica Dominicana 1
EC - Ecuador 1
EE - Estonia 1
EG - Egitto 1
GE - Georgia 1
GH - Ghana 1
IQ - Iraq 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
MA - Marocco 1
PK - Pakistan 1
PT - Portogallo 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 12.577
Salva come PNG Salva come JPEG
Città #
Dublin 1.510
Chandler 1.272
Jacksonville 800
Nyköping 727
Singapore 632
Messina 333
Beijing 321
Ashburn 284
Princeton 279
Dearborn 268
Medford 258
Des Moines 212
Cambridge 209
Ann Arbor 185
Warsaw 174
Boardman 139
New York 82
Woodbridge 77
Wilmington 63
Budapest 59
San Mateo 56
Brussels 54
Jinan 50
Los Angeles 44
Shenyang 41
Nanjing 38
Vienna 37
Hebei 36
Lancaster 36
Tianjin 34
Bremen 32
Pune 32
Helsinki 31
Seattle 29
Dong Ket 27
Munich 27
Hangzhou 25
Houston 24
Zhengzhou 24
Jakarta 23
Strasbourg 23
Milan 22
Ningbo 20
Haikou 18
Rome 16
Norwalk 15
Auburn Hills 14
Falls Church 14
Palermo 14
Washington 14
Guangzhou 13
Ottawa 12
Amsterdam 11
Hyderabad 11
Lanzhou 11
Nanchang 11
Augusta 10
Catania 10
Jiaxing 10
Taizhou 10
Fuzhou 9
Taiyuan 9
Changsha 8
Monmouth Junction 8
Ardabil 7
Brno 7
Frankfurt am Main 7
London 7
Cosenza 6
Leawood 6
Shanghai 6
Bergamo 5
Capoterra 5
Latina 5
Piazza Armerina 5
Redwood City 5
Turin 5
Xi'an 5
Espoo 4
Ferrandina 4
Francofonte 4
Hefei 4
Limina 4
Modica 4
Mumbai 4
Petrosino 4
Santa Clara 4
Acireale 3
Brindisi 3
Chapel Hill 3
Esher 3
Florence 3
Fremont 3
Gangdong-gu 3
Grammichele 3
Hong Kong 3
Kelowna 3
Kunming 3
Lappeenranta 3
Lausanne 3
Totale 9.053
Salva come PNG Salva come JPEG
Nome #
Altered Microrna Expression Profile in the peripheral Lymphomonocytes of Multiple Myeloma Patients with Bisphosphonate-Induced Osteonecrosis of the Jaw 152
Diagnostic utility of Sudoscan for detecting Bortezomib-induced painful neuropathy 115
Effect of therapeutic plasma exchange on plasma levels of oxidative biomarkers in a patient with thrombotic thrombocytopenic purpura 110
Low-energy laser irradiation promotes cellular damage in glucocorticoid-resistant multiple myeloma cells. 99
Raman spectroscopy differentiates between sensitive and resistant multiple myeloma cell lines 99
Phage-AgNPs complex as SERS probe for U937 cell identification 95
The cancer stem cell hypothesis: a guide to potential molecular targets. 92
Comportamento di alcuni indici della fibrinolisi in dislipidemici in corso di trattamento con sinfibrato" 92
Corneal Structural Changes in Nonneoplastic and Neoplastic Monoclonal Gammopathies 91
L'ipersplenismo: attualità e prospettive future 90
Cutaneous adverse reactions to lenalidomide. 87
Role of the microbiota in hematologic malignancies. 86
Absence of the V617F JAK2 Mutation in the Lymphoid Compartment in a Patient with Essential Thrombocythemia and B-Chronic Lymphocytic Leukemia and in Two Relatives with Lymphoproliferative Disorders 84
Disappearance of Acquired Hemophilia A after Complete Remission in a Multiple Myeloma Patient. 82
Efficacia della chemioterapia convenzionale ad alte dosi in un caso di mieloma multiplo IgM primitivamente doppio-refrattario ai nuovi farmaci 82
Altered microRNA expression profile in the peripheral lymphoid compartment of multiple myeloma patients with bisphosphonate-induced osteonecrosis of the jaw 82
Bisphosphonates induce apoptosis of circulating endothelial cells in multiple myeloma patients and in subjects with bisphosphonate-induced osteonecrosis of the jaws 82
Challenge test to bisphosphonates in patients with hypersensitivity reactions to drugs. 81
Patients with bisphosphonate-associated osteonecrosis of the jaw have unmodified levels of soluble vascular endothelial growth factor receptor 1. 80
MDR-1 gene polymorphisms G2677T and C3435T in a case of Hodgkin's variant of Richter's syndrome 80
Novel therapeutic strategies in multiple myeloma: role of the heat shock protein inhibitors 79
SIRT1 and SIRT2 Expression correlates with advanced disease and bone lesions in Multiple Myeloma 79
E rosette formation in B cell chronic lymphocytic leukemia. 77
Telomerase and telomere biology in hematological diseases: A new therapeutic target 77
Anticancer Activity of Curcumin and Its Analogues: Preclinical and Clinical Studies 77
Bisphosphonate-associated osteonecrosis of the jaw in patients with multiple myeloma and breast cancer. 76
Extramedullary plasmacytoma of the maxilla simulating a maxillary radicular cyst: Quick diagnosis and management 74
Evaluation of the AGE/sRAGE Axis in Patients with Multiple Myeloma 74
ASSETTO EMATOLOGICO DI UN GRUPPO DI SOGGETTIAFFETTI DA MORBO DI COOLEY:STUDIO DEL COMPORTAMENTO DELL'ERITROPOIETINA PLASMATICA 71
Circulating levels of intercellular adhesion Molecule-1 (ICAM-1) and soluble Interleukin 2 receptors(IL-2R) in patients with B cell Chronic Lynphocityc Leukemia 70
Curcumin ameliorates the in vitro efficacy of carfilzomib in human multiple myeloma U266 cells targeting p53 and NF-kB pathways 68
Angiogenesis in patients with biphosphonate-associated osteonecrosis of the jaw 67
Absence of the V617F JAK2 mutation in the lymphoid compartment in a patient with essential thrombocythemia and B-chronic lymphocytic leukemia and n two relatives with lymphoproliferative disorders 67
ARA-C a basse dosi nelle sindrome mielodisplastiche in differenti stati evolutivi 67
Aggregazione piastrinica in dislipidemici in corso di trattamento con simfibrato 67
Adoptive immunotherapy for hematological malignancies: Current status and new insights in chimeric antigen receptor T cells 67
Immunoproteasome-selective and non-selective inhibitors: A promising approach for the treatment of multiple myeloma. 67
How gene polymorphisms can influence clinical response and toxicity following R-CHOP therapy in patients with diffuse large B cell lymphoma 67
A rare spinal localization of gray zone lymphoma without mediastinal involvement: A case report and review of literature 67
EVALUATION OF DECORIN AND BIGLYCAN GENE EXPRESSION IN LYMPHOCYTES FROM PATIENTS WITH CHRONIC LYMPHATIC LEUKAEMIA. 66
Circulating levels of intercellular adhesion molecule-1 (ICAM-1) and soluble interleukin 2 receptors (IL-2R) in patients with B cell chronic lymphocytic leukaemia. 66
Beta 2 microglobulina ed emopatie maligne 66
A micro-Raman spectroscopic investigation of leukemic U-937 cells in aged cultures 66
Vaccination of multiple myeloma: Current strategies and future prospects 66
Evaluation of Interleukin-17 serum levels in patients with chronic myeloproliferative diseases. 65
Immunohistochemical evaluation of sarcoglycans and integrin in gingival epithelium of multiple myeloma patients with bisphosphonate-induced osteonecrosis of the jaw 65
A multivariate analysis of Multiple Myeloma subtype plasma cells 65
Assenza della mutazione JAK2 V617F nel compartimento linfoide di un paziente affetto da trombocitemia essenziale e leucemia linfatica cronica a cellule B ed in due parenti affetti da disordini linfoproliferativi 64
Serum levels of soluble ICAM-1 in patients with malignant lymphoma in association with treatment response. 64
Antiresorptive Agents and Anti-Angiogenesis Drugs in the Development of Osteonecrosis of the Jaw. 64
Serum levels of interleukin-16 in lymphoid malignancies. 63
Increased levels of the soluble adhesion molecule E-selectin in patients with chronic myeloproliferative disorders and thromboembolic complications 63
Immunohistochemical evaluation of sarcoglycans and integrins in gingival epithelium of multiple myeloma patients with bisphosphonate-induced osteonecrosis of the jaw. 62
Circulating microRNAs: New biomarkers in diagnosis, prognosis and treatment of cancer (Review). 62
ABERRANT EXPRESSION OF CANCER TESTIS ANTIGENS IN HEMATOLOGIC MALIGNANCIES 61
Amyloid myopathy presenting with rhabdomyolysis: Evidence of complement activation 60
Vaccination strategies in lymphoproliferative disorders: Failures and successes 60
Triplet vs doublet lenalidomide-containing regimens for the treatment of elderly patients with newly diagnosed multiple myeloma 60
Evaluation of circulating endothelial cells, VEGF and VEGFR2 serum levels in patients with chronic myeloproliferative diseases. 59
Carbonyl groups serum levels are associated with CD38 expression in patients with B chronic lymphocytic leucemia. 59
Elevated srum concentration of angiopoietin-2 in patients with multiple myeloma: correlation with markers of disease 58
Risk of occult hepatitis B virus infection reactivation in patients with solid tumours undergoing chemotherapy 58
A progression-risk score to predict treatment-free survival for early stage chronic lymphocytic leukemia patients 58
Evaluation of hepatitis B and C virus infections in patients with non-Hodgkin's lymphoma and without liver disease 57
Concentration of circulating endothelial progenitor cells (EPC) in normal pregnancy and in pregnant women with diabetes and hypertension 57
Successful management of a pregnant patient with chronic myeloid leukemia receiving standard dose imatinib 57
ABVD vs BEACOPP escalated in advanced-stage Hodgkin's lymphoma: Results from a multicenter European study 57
Avascular Necrosis of Bone in Leukemia and Osteonecrosis of Jaw by Bisphosphonates 56
Lipid profile in hematologic neoplasms 55
Circulating endothelial progenitor cells and angiogenic serum factors in patients with chronic myeloproliferative diseases 55
MDR-1 polymorphisms (G2677T and C3435T) in B-chronic lymphocytic leukemia: an impact on susceptibility and prognosis. 55
Decreased plasma levels of IL-33 could contribute to the altered function of Th2 Iymphocytes in patients with poIycythemia vera and essential thrombocythemia. 55
FITC-labelled clone from phage display for direct detection of leukemia cells in blood 55
Risk stratification and early cardiotoxicity identification: organizational advantages and clinical impact of intrahospital cardiotoxicity network 55
Severe dermatologic adverse reactions after exposure to lenalidomide in multiple myeloma patients with a positive HLA-DRB1*1501 and HLA-DQB1*0602. 55
SOLUBLE ANGIOGENIC FACTORS: IMPLICATIONS FOR CHRONIC MYELOPROLIFERATIVE DISORDERS 54
Increase in serum protein carbonyl groups is associated with more advanced stage of disease in multiple myeloma patients. 54
Hepatitis B Virus Causes Epigenetic Induction of Interleukin-8Production which in Turn Inhibits Interferon-alfa Antiviral Activity 54
Possible role of Interleuki-31/33 Axis in Imatinib Mesylate-Associated Skin Toxicity 54
Recombinant human granulocyte colony-stimulating factor reverts vascular dysfunction 53
MARKERS OF ENDOTHELIAL AND PLATELET STATUS IN PATIENTS WITH ESSENTIAL THROMBOCYTHEMIA AND PLYCYTHEMIA VERA 53
Evaluation des sous-populations lymphocytaires chez des travailleurs exposés a basse dose du benzene. Données préliminaires”. 53
Cardiac involvement in patients with hematologic malignancies. 53
Curcumin Ameliorates the In Vitro Efficacy of Carfilzomib in Human Multiple Myeloma U266 Cells Targeting p53 and NF-κB Pathways. 53
Patients with bisphosphonates-associated osteonecrosis of the jaw have reduced circulating endothelial cells 53
Changes in serum interleukin-8 and sRAGE levels in multiple myeloma patients 53
A phase 2 study of three low-dose intensity subcutaneous bortezomib regimens in elderly frail patients with untreated multiple myeloma 53
Purpuric gloves and socks syndrome caused by parvovirus B19 infection 52
Efficacia di Nilotinib in un giovane paziente affetto da LMC ad alto rischio Sokal in fallimento dopo inatinib ad alte dosi 52
The adipose organ and multiple myeloma: Impact of adipokines on tumor growth and potential sites for therapeutic intervention 52
Antiproliferative effects of st. John’s wort, its derivatives, and other hypericum species in hematologic malignancies 52
Chromosome 1 abnormalities in elderly patients with newly diagnosed multiple myeloma treated with novel therapies. 51
JAK2 V617F-positive latent essential thrombocythemia and splanchnic vein thrombosis: the role of bone marrow biopsy for the diagnosis of myeloproliferative disease. 51
Interleukin 22 is increased and correlated with CD38 expression in patients with B-chronic lymphocytic leukemia 51
SIRT2 and SIRT3 expression correlates with redox imbalance and advanced clinical stage in patients with multiple myeloma 51
Effetti di uno stress fisico sulla funzione pistrinica e su alcuni parametri emocoagulativi e della fibrinolisi 50
MicroRNA profiling in asthma: Potential biomarkers and therapeutic targets 50
Cellule endoteliali progenitrici circolanti e osteonecrosi mascellare da bifosfonati. 49
Prognostic value of serum thymidine kinase and beta 2 microglobulin in subjects affected by multiple myeloma 49
Cerebral venous sinus thrombosis (CVST) associated with SARS-CoV-2 vaccines: clues for an immunopathogenesis common to CVST observed in COVID-19 49
Totale 6.687
Salva come PNG Salva come JPEG
Categoria #
all - tutte 61.994
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 61.994
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020902 0 0 0 0 0 0 209 145 27 243 258 20
2020/20211.766 211 38 300 91 150 174 36 170 133 243 120 100
2021/20221.637 16 118 24 73 54 23 101 65 54 225 222 662
2022/20234.587 409 392 215 409 312 466 53 231 1.862 27 146 65
2023/20241.087 100 197 70 85 98 247 26 71 11 27 16 139
2024/20251.160 136 85 99 337 304 143 56 0 0 0 0 0
Totale 12.984